归创通桥医疗科技股份有限公司（股票代码：02190）于2026年7月7日发布公告，披露公司在香港联交所进行了股份回购。具体如下：
2026年7月7日，公司场内回购普通股H股59,000股，约占回购前已发行股本的0.0178%。回购价格区间为每股19.35港元至19.86港元，总金额为1,150,685港元，折合约115.07万港元。回购完成后，公司最新已发行股份（不包括库存股份）合计323,898,613股，库存股份12,452,131股，合计336,350,744股。
公司于2026年5月13日通过购回授权，可购回的股份总数为32,715,311股，目前已累计回购3,305,500股，占授权当日已发行股份总数的约0.9869%。本次回购的59,000股将作为公司库存股份持有。公司表示，已严格遵守香港联交所证券上市规则及相关法律规定，所有环节均获得董事会正式授权并符合适用条款。
公告由董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.